Posts

Showing posts from July, 2024

Nighttime Workouts Better for Lowering Blood Glucose?

The timing, as well as the amount, of daily physical activity was linked to better glucose control in sedentary adults with overweight or obesity and metabolic dysfunction, a study finds. Medscape Medical News source https://www.medscape.com/viewarticle/nighttime-workouts-better-lowering-blood-glucose-2024a1000cfy?src=rss

French Doctors Have Concerns About the Legislative Elections

The dissolution of the government and call for elections have delayed, and perhaps thwarted, several anticipated health initiatives. Medscape Medical News source https://www.medscape.com/viewarticle/french-doctors-have-concerns-about-legislative-elections-2024a1000cfx?src=rss

OAC, AF, and Recurrent Stroke Risk: New Data

Despite secondary prevention with OAC, the risk for recurrent stroke and mortality is high in patients with AF. However, OAC discontinuation is tied to a doubling of recurrent stroke. Medscape Medical News source https://www.medscape.com/viewarticle/oral-anticoagulation-af-and-recurrent-stroke-risk-new-data-2024a1000cfw?src=rss

Weight Gain From Discontinuing GLP-1s a Concern in Pregnancy

Women are recommended to discontinue the weight loss/type 2 diabetes drugs months before conceiving, but that places them in a rebound mode of weight gain and reversal of glycemic benefits. Medscape Medical News source https://www.medscape.com/viewarticle/weight-gain-discontinuing-glp-1s-concern-pregnancy-2024a1000cfv?src=rss

Uveitis in Children Linked to Higher Cataract Risk

Children with uveitis had a higher risk of developing cataracts than those without the condition, necessitating close monitoring of cataract development in these patients. Medscape Medical News source https://www.medscape.com/viewarticle/uveitis-children-linked-higher-cataract-risk-2024a1000cdx?src=rss

Reimagining Obesity Care for PCPs

A large health system has implemented embedded obesity management into its primary care system. Could the approach work for your group? Medscape Medical News source https://www.medscape.com/viewarticle/reimagining-obesity-care-pcps-2024a1000cdv?src=rss

Female Anesthesia Providers Improve Surgical Safety

The association between female providers and complications was more pronounced among veteran clinicians, but the effect did not persist in the postoperative period. Medscape Medical News source https://www.medscape.com/viewarticle/female-anesthesia-providers-improve-surgical-safety-2024a1000cdu?src=rss

Biologics Outperform Methotrexate in PsA Prevention

Biologic agents may help to prevent psoriatic arthritis in patients with psoriasis to a greater extent than methotrexate. Medscape Medical News source https://www.medscape.com/viewarticle/biologic-agents-show-lower-psoriatic-arthritis-incidence-2024a1000car?src=rss

WHO Warns Against Counterfeit Ozempic in Europe and the USA

The high demand for Ozempic has exceeded production capacity and made the drug an attractive target for counterfeiters. Medscape Medical News source https://www.medscape.com/viewarticle/who-warns-against-counterfeit-ozempic-europe-and-united-2024a1000caq?src=rss

Labetalol, Nifedipine: Outcome on Pregnancy Hypertension

Treatment for chronic hypertension in pregnancy with labetalol showed no significant differences in maternal or neonatal outcomes compared with treatment with nifedipine. MDedge News source https://www.medscape.com/s/viewarticle/labetalol-nifedipine-outcome-pregnancy-hypertension-2024a1000cap?src=rss

CAR-T Therapies May Be Linked to Secondary Tumors

The European Medicines Agency recently examined secondary tumors that developed in 38 out of approximately 42,500 patients who were administered CAR-T cells. Medscape Medical News source https://www.medscape.com/viewarticle/car-t-therapies-may-be-linked-secondary-tumors-2024a1000c7j?src=rss

Only One Quarter of Americans Who Need OUD Meds Get Them

Investigators also noted continuing disparities in prescribing, with women and Black and Hispanic individuals less likely to get an OUD medication. Medscape Medical News source https://www.medscape.com/viewarticle/only-one-quarter-americans-who-need-oud-meds-get-them-2024a1000c7i?src=rss

Reteplase Superior to Alteplase in Chinese Stroke Trial

The double-bolus thrombolytic gave a higher rate of excellent functional outcomes in the RAISE trial. Medscape Medical News source https://www.medscape.com/viewarticle/reteplase-superior-alteplase-chinese-stroke-trial-2024a1000c55?src=rss